Reformulation strategies to enhance and extend your drug products success

Extend the lifecycle of your small or large molecule drug with the right reformulation approach

6

July

  • 15:00 BST | 16:00 CET
  • Free
  • Why attend?
  • Speakers
  • Contact Us

Why attend?

This webinar will focus on the strategies for reformulation and how they can be used to extend the lifecycle of both small and large molecule-based drugs. Reformulating drug products can have several benefits ranging from improving patient centricity to boosting solubility or stability.

3 key learning objectives from this webinar:

  • Understand the different aspects involved in reformulation of an existing drug product.
  •  Explore different ways to maximise the benefits of reformulation.
  • Gain an understanding of Recipharm’s capability to partner with you for your reformulation needs.

 

Recipharm speakers:

  • Balasubramaniam Jagdish, PhD, Assistant Vice President Formulation Development
  • Dr Uwe Hanenberg, PhD, Head of Product Development
  • Maria Lundin Johnson, PhD, Head of Formulation Development

 

During the webinar, they will cover:

  • The available reformulation strategies and how they help in the lifecycle management of drug products.
  • The regulatory challenges that need to be considered for reformulation.

 

They will also present a range of examples and case studies to bring to life the benefits of reformulation strategies and provide an insight into the challenges that need to be overcome.

Speakers

Select a speaker to learn more

Back
Maria Lundin Johnson, PhD
Head of Formulation Development, Recipharm

Maria is the Head of Formulation Development at Recipharm. Maria has a master’s degree in chemical engineering towards pharma and a PhD in Physical Chemistry from Stockholm Royal Institute of Technology.

Maria has 15 years of experience in formulation development from academia, research institutes, and industry such as KTH, RISE, and Nanologica. She has worked with pre-clinical development and early clinical phase development (CTM)​ with a broad range of dosage forms including sterile products. She has a particular interest in encapsulation and controlled release of APIs in formulations as well as coating technologies and experience in formulations with peptides and proteins.

Next speaker
Back
Uwe Hanenberg, PhD
Head of Product Development, Recipharm

Dr. Uwe Hanenberg, Head of Product Development, Oral Solid Dose (OSD) at Recipharm. Uwe is responsible for implementing and executing the OSD product development strategy that assures science driven, timely development of new products or services.
Uwe has 25 years of experience in the pharmaceutical industry with Bayer, Altana, Grünenthal and Catalent. He has held several leading positions in quality, manufacturing and packaging, product development, project management within the science & technology sphere. His areas of expertise are oral formulation development, oral manufacturing technologies, stick pack technologies and pharmaceutical contract services and project management.

 

Next speaker
Back
Balasubramaniam Jagdish, PhD
Assistant Vice President, Formulation Development, Recipharm

Balasubramaniam Jagdish, PhD, Assistant Vice President, Formulation Development at Recipharm. Bala is leading the formulation development at Recipharm’s Bengaluru facility in India. He holds a PhD degree in Pharmaceutics (Indian Institute of Technology, Banaras Hindu University) and a Diploma in Intellectual Property Management and Clinical Studies Management. He has worked in the Pharmaceutical Industry since 2003, mostly in the area of Product Development, for both generics and NCEs, specialising in Oral Solid Dose forms.

Next speaker

Enquiry